|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/02 | |
| A61K 38/08 |
| (11) | Patento numeris | 2793919 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12809126.1 |
| Europos patento paraiškos padavimo data | 2012-12-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/005362 |
| Data | 2012-12-21 |
| (87) | Numeris | WO 2013/091896 |
| Data | 2013-06-27 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2011/0064 | 2011-12-21 | WO |
| (72) |
COMBETTE, Jean-Marc, FR
DELOCHE, Catherine, CH
|
| (73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
| (54) | NOVEL JNK INHIBITOR MOLECULES FOR TREATMENT OF VARIOUS DISEASES |
| NOVEL JNK INHIBITOR MOLECULES FOR TREATMENT OF VARIOUS DISEASES |